Recent PBYI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:41:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:32:47 PM
- Puma Biotechnology Reports First Quarter 2026 Financial Results • Business Wire • 05/07/2026 08:05:00 PM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/06/2026 09:15:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:17:32 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:17:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:15:33 PM
- Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results • Business Wire • 04/23/2026 08:15:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/07/2026 09:11:29 PM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/02/2026 09:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 09:41:18 PM
- Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results • Business Wire • 02/26/2026 09:05:00 PM
- Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference • Business Wire • 02/23/2026 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2026 01:28:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2026 01:28:04 AM
- Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results • Business Wire • 02/12/2026 09:07:00 PM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 02/04/2026 10:05:00 PM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/07/2026 10:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/07/2026 09:28:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/07/2026 09:25:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/07/2026 09:24:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/06/2026 09:53:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/06/2026 09:45:54 PM
- Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) • Business Wire • 12/22/2025 09:10:00 PM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 12/02/2025 10:15:00 PM
